Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS
· Delayed Price · Currency is USD
8.56
+1.06 (14.13%)
At close: May 22, 2025
RAJAF Revenue
In the year 2023, Cordyceps Sunshine Biotech Holdings had annual revenue of $882.53K with 1,555.66% growth. Cordyceps Sunshine Biotech Holdings had revenue of $315.50K in the quarter ending December 31, 2023, with 210.58% growth.
Revenue
882.53K
Revenue Growth
-14.10%
P/S Ratio
1,077.79
Revenue / Employee
58.84K
Employees
15
Market Cap
951.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 882.53K | 829.23K | 1,555.66% |
| Dec 31, 2022 | 53.30K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 202.08K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition